Fujifilm Holdings Corp said it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States.
The trial will enrol about 50 COVID-19 patients in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital, and the University of Massachusetts Medical School, Fujifilm said on Thursday.
On March 31, Fujifilm announced the start of phase III clinical trial of Avigan for COVID-19 patients in Japan.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
